June 3rd, 2011 by Glenn Laffel, M.D., Ph.D. in Opinion
No Comments »
The Health Tech 2011 Conference, held earlier this month in Boston, featured presentations from startup CEOs in the health and wellness space. The conference had nothing to do with gender issues or leadership per se. Yet the Twitter feed from the conference (#ciht11) contained this:
@ml_barnett By my count, only 3 of 27 speakers are women. RT @taracousphd: where are the female entrepreneurs? It’s healthcare!!!
taracousphd and @ml_barnett reminded us of a painful fact. There aren’t many female CEOs in Health IT. Why is this?
Women certainly aren’t short on content knowledge in health care. In fact, they dominate men in this area. More than 40% of all practicing physicians and 50% of all medical school graduates are women. Women earn nearly 3 times more PhDs in psychology (useful content knowledge for startups in the space covered by Health Tech 2011). Nearly 94% of nurses and 74% of physical therapists are women, and they rule the workforce in public health, social services and pharmacy as well.
The problem–and it’s a big one–has to do with the ‘IT’ part of ‘Health IT.’ In 2008, only 6% of Fortune 500 technology companies had female CEOs and 13% had women corporate officers of any kind, according to the National Center for Women and Information Technology. Among tech startups that raised venture capital in 2009, only 4.3% were led by female chief executives. A recent Business Week list of the ‘best young entrepreneurs in tech’ included 45 people, only 3 of which were women.
Among the many explanations for the gender disparity among chief executives in IT, the 4 that make the most sense to me are these: Read more »
*This blog post was originally published at Pizaazz*
May 28th, 2011 by Glenn Laffel, M.D., Ph.D. in News
No Comments »
“The combined profits of the Fortune 500 increased by 81% this year, the third largest gain in history. Compare that to the unemployment rate, which fell by just 8% over the past 12 months.” Ezra Klein, while analyzing last week’s jobs report by the Federal Government.
“Why would I listen to ‘lub dub’ when I can see everything?” Eric Topol, a cardiologist in San Diego who carries a portable ultrasound device with him in lieu of a stethoscope. The device lets him and his patient see the heart muscle and valves, and blood flow into and out of the organ.
“There probably is not a whole lot that we can do at the pipeline level to dramatically improve the number of students choosing primary care. Where the money is, is where the money is.” Mark Schwartz, an associate professor at the NYU School of Medicine, discussing a study showing that high medical school debt and low compensation are driving people away from General Internal Medicine.
“It sounds like a new Apple product.” Bara Vada, describing IPAB, the Independent Payment Advisory Board, a controversial panel tasked by the Affordable Care Act to make binding recommendations to reduce Medicare spending. Read more »
*This blog post was originally published at Pizaazz*
May 20th, 2011 by Glenn Laffel, M.D., Ph.D. in Health Policy, News, Research
No Comments »
It was 1999 when the Federal government first acknowledged our nation had a problem with race and health care. That year, Congress tasked the Institute of Medicine to study the matter, and the resulting report was not good. Minorities were in poor health and receiving inferior care, the report said. They were less likely to receive bypass surgery, kidney transplants and dialysis. If they had diabetes, they were more likely to undergo amputations, meaning their disease had been poorly controlled. And there was a lot more where that came from.
The IOM report was a call to action. In subsequent years, lawmakers crafted policies and established goals for improvement. Federal and state governments and numerous foundations set aside billions to fund projects. Health services researchers expanded their efforts to study the problem.
Twelve years later, we have something to show for the effort. Steep declines in the prevalence of cigarette smoking among African Americans have narrowed the gap in lung cancer death rates between them and whites, for example. Inner city kids have better food choices at school. The 3-decade rise in obesity rates, steepest among minorities, has leveled off.
Nevertheless, racial disparities persist across the widest possible range of health services and disease states in our country. The overall death rate from cancer is 24% higher for African-Americans than white people. The racial gap in colorectal cancer mortality has widened since the 1980s. African Americans with diabetes experienced declines in recommended foot, eye, and blood glucose testing between 2002-2007. Read more »
*This blog post was originally published at Pizaazz*
May 13th, 2011 by Glenn Laffel, M.D., Ph.D. in Health Policy, Health Tips
No Comments »
Like everybody else, physicians are expanding their online personal identities. At the same time, they are trying to comply with codes of conduct that help consumers trust them and their profession.
There’s no problem so long as the personal online activities of physicians don’t jeopardize their obligations as professionals, which means that there is a problem, unfortunately.
In a recent study for example, 17% of all blogs authored by health professionals were found to include personally identifiable information about patients. Scores of physicians have been reprimanded for posting similar information on Twitter and Facebook, posting lewd pictures of themselves online, tweeting about late night escapades which ended hours before they performed surgery, and other unsavory behaviors.
As I mentioned Monday, medical students and younger physicians who grew up with the Internet have to be particularly careful, since they had established personal online identities before accepting the professional responsibilities that came with their medical degree. Read more »
*This blog post was originally published at Pizaazz*
May 2nd, 2011 by Glenn Laffel, M.D., Ph.D. in Health Policy, Opinion
1 Comment »
For the first time in 30 years, an expert panel has updated guidelines for the diagnosis of Alzheimer’s disease. The long overdue facelift should favorably impact care for millions and accelerate badly needed research on the disease.
The guidelines were produced by representatives from the National Institute on Aging and the Alzheimer’s Association. They portray Alzheimer’s for the first time as a three-stage disease. In addition to ‘Stage 3,’—the full-blown clinical syndrome that had been described in earlier versions of the guidelines—the new guidelines describe an earlier ‘Stage 2,’ of mild cognitive impairment due to Alzheimer’s, and a ‘Stage 1, or preclinical’ phase of the disease. The latter can only be detected with biochemical marker tests and brain scans.The guidelines legitimize years’ worth of observations by the family members of Alzheimer’s patients, who recognize in retrospect that Grandpa had a slowly progressive cognitive disorder long before he was diagnosed. The guidelines also reflect progress on the research front, where it has now been established that the disease begins years before patients become symptomatic.
Alzheimer’s patients and their families, and the teetering US health system that supports them, would have been better served by the publication of these guidelines 2-3 years ago. Read more »
*This blog post was originally published at Pizaazz*